Colorectal cancer patients with PolE mutations are typically diagnosed younger than patients with wild-type PolE (median of 54.5 years vs. 67.2 years, p < 0.0001) and at an earlier disease stage (p = 0.006, x2 test for trend). This evidence concerns the gene POLE and colorectal cancer.